RxSight (RXST) Interest Coverage Ratio (2020 - 2026)
RxSight (RXST) posted Interest Coverage Ratio of 1.19 for Q1 2026, up 72.58% on a QoQ basis from 4.32 in Q4 2025, and down 464.25% year-over-year from 0.33 in Q1 2025.
RxSight (RXST) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
RxSight's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 1.19 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 464.25% year-over-year to 1.19 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.68 (down 406.94% YoY) and the FY2025 annual result came in at 13.04, down 4221.1% from the prior year.
- Interest Coverage Ratio was 1.19 for Q1 2026 at RxSight, up from 4.32 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 82.08 in Q4 2023 and bottomed at 16.64 in Q4 2024.
- A 5-year average of 2.66 and a median of 0.12 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio surged 894.49% — and 2025, when it plunged 13650.6%.
- RxSight's Interest Coverage Ratio stood at 10.33 in 2022, then jumped by 894.49% to 82.08 in 2023, then sank by 120.27% to 16.64 in 2024, then jumped by 74.01% to 4.32 in 2025, then jumped by 72.58% to 1.19 in 2026.
- Business Quant data shows RXST's Interest Coverage Ratio at 1.19 in Q1 2026, 4.32 in Q4 2025, and 0.73 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -1.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 |
| Dec 31, 2025 | -4.32 |
| Sep 30, 2025 | -0.73 |
| Jun 30, 2025 | -4.44 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -16.64 |
| Sep 30, 2024 | -0.05 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | 82.08 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | -10.33 |
| Sep 30, 2022 | 1.07 |
| Jun 30, 2022 | 0.74 |
| Mar 31, 2022 | -1.01 |
| Dec 31, 2021 | 269.80 |
| Sep 30, 2021 | 0.73 |
| Jun 30, 2021 | -0.30 |